Hayriye Daloğlu
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Hayriye Daloğlu has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Akif Yeşilipek
Department of Pediatric Bone Marrow Transplantation Unit MedicalPark Antalya Hospital Antalya Turkey
1 shared publication - Gülsün Karasu
Department of Pediatric Bone Marrow Transplantation Unit, MedicalPark Göztepe Hospital, İstanbul, Turkey
1 shared publication - Koray Yalçın
Pediatric Hematopoietic Stem Cell Transplant Bahcesehir University Goztepe Medicalpark Hospital Istanbul, Turkey
1 shared publication - Nazan Özsan
Department of Pathology, Ege University Faculty of Medicine, Izmir 35100, Türkiye
1 shared publication - Seda Oztürkmen
Department of Pediatric Bone Marrow Transplantation Unit, MedicalPark Antalya Hospital, Antalya, Turkey
1 shared publication - Vedat Uygun
İstinye University, Faculty of Medicine, MedicalPark Antalya Hospital, Department of Pediatric Bone Marrow Transplantation Unit, Antalya, Turkey
1 shared publication
Latest Publications
- 26 November 2021
- Published by Springer Nature in International Journal of Hematology
- Vol. 115 (4) , 600-604
Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide
EBV-associated lymphoproliferative disorders (LPDs) are common in hematopoietic stem cell transplantation (HSCT) with T-cell-depleted grafts, but are extremely rare in HSCT patients with T-cell-replete grafts with post-transplant cyclophosphamide (PTCy). Here we present the cases of two pediatric patients who developed EBV-related LPD after T-cell-replete haplo-HSCT with PTCy. One of these is the first reported case of EBV-positive mucocutaneous ulcer (EBVMCU) developing after PTCy. EBV-related diseases are rare in T-cell-replete haplo-HSCT patients with PTCy. However, in patients with risk factors, it is reasonable to screen for EBV viremia for LPD.
- 26 November 2021
- Published by Springer Nature in International Journal of Hematology
- Vol. 115 (4) , 600-604
Epstein-Barr virus-related lymphoproliferative disorders in T-cell repleted haploidentical transplantation with post-transplant cyclophosphamide
EBV-associated lymphoproliferative disorders (LPDs) are common in hematopoietic stem cell transplantation (HSCT) with T-cell-depleted grafts, but are extremely rare in HSCT patients with T-cell-replete grafts with post-transplant cyclophosphamide (PTCy). Here we present the cases of two pediatric patients who developed EBV-related LPD after T-cell-replete haplo-HSCT with PTCy. One of these is the first reported case of EBV-positive mucocutaneous ulcer (EBVMCU) developing after PTCy. EBV-related diseases are rare in T-cell-replete haplo-HSCT patients with PTCy. However, in patients with risk factors, it is reasonable to screen for EBV viremia for LPD.